Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 2
1980 2
1981 3
1982 4
1983 4
1984 1
1985 1
1986 2
1987 4
1988 4
1989 1
1990 3
1991 1
1992 1
1996 1
1998 1
1999 1
2000 1
2003 2
2004 1
2005 1
2006 1
2007 2
2009 3
2010 3
2012 2
2013 4
2014 1
2015 5
2016 4
2018 2
2019 3
2020 4
2021 4
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Garvey WT, et al. Lancet. 2023 Aug 19;402(10402):613-626. doi: 10.1016/S0140-6736(23)01200-X. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385275 Clinical Trial.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Pettus J, et al. Among authors: klaff lj. Nat Med. 2022 Oct;28(10):2092-2099. doi: 10.1038/s41591-022-02011-x. Epub 2022 Oct 3. Nat Med. 2022. PMID: 36192552 Free PMC article. Clinical Trial.
Sulfonylureas and platelet function.
Klaff LJ, Kernoff L, Vinik AI, Jackson WP, Jacobs P. Klaff LJ, et al. Am J Med. 1981 Mar;70(3):627-30. doi: 10.1016/0002-9343(81)90585-4. Am J Med. 1981. PMID: 6782875 Review.
The incidence and causes of hypercalcaemia.
Dent DM, Miller JL, Klaff L, Barron J. Dent DM, et al. Among authors: klaff l. Postgrad Med J. 1987 Sep;63(743):745-50. doi: 10.1136/pgmj.63.743.745. Postgrad Med J. 1987. PMID: 3444797 Free PMC article.
Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test.
Arnold WD, Kupfer K, Hvidsten Swensen M, Fortner KS, Bays HE, Davis M, Klaff LJ, San George RC. Arnold WD, et al. Among authors: klaff lj. J Diabetes Sci Technol. 2020 Sep;14(5):890-895. doi: 10.1177/1932296819831273. Epub 2019 Mar 6. J Diabetes Sci Technol. 2020. PMID: 30841743 Free PMC article.
86 results